The role of BAFF in immune function and implications for autoimmunity

被引:105
作者
Kalled, SL [1 ]
机构
[1] Biogen Idec Inc, Cambridge, MA 02142 USA
关键词
D O I
10.1111/j.0105-2896.2005.00219.x
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
BAFF [B-cell activating factor belonging to the tumor necrosis factor (TNF) family] is a ligand that is required for peripheral B-cell survival and homeostasis. In addition to mediating B-cell survival, BAFF also regulates expression of certain B-cell-surface proteins, such as CD21/35. BAFF deficiency results in a reduced number of peripheral B cells and a diminished ability to mount robust humoral immune responses. Overexpression of BAFF has been linked to murine and human autoimmunity, and recent data provide clues as to how excess BAFF may allow the emergence of autoreactive B cells. In vivo animal testing with BAFF inhibitors has generated exciting data that support the pathway as a target for modulating B cells. The role of BAFF in B-cell biology, T-cell biology, and autoimmunity is discussed, as well as current efforts to develop BAFF inhibitors for clinical testing in autoimmune disorders.
引用
收藏
页码:43 / 54
页数:12
相关论文
共 81 条
[31]   BAFF/BLyS receptor 3 binds the B cell survival factor BAFF ligand through a discrete surface loop and promotes processing of NF-κB2 [J].
Kayagaki, N ;
Yan, MH ;
Seshasayee, D ;
Wang, H ;
Lee, W ;
French, DM ;
Grewal, IS ;
Cochran, AG ;
Gordon, NC ;
Yin, JP ;
Starovasnik, MA ;
Dixit, VM .
IMMUNITY, 2002, 17 (04) :515-524
[32]   Severe B cell hyperplasia and autoimmune disease in TALL-1 transgenic mice [J].
Khare, SD ;
Sarosi, I ;
Xia, XZ ;
McCabe, S ;
Miner, K ;
Solovyev, I ;
Hawkins, N ;
Kelley, M ;
Chang, D ;
Van, G ;
Ross, L ;
Delaney, J ;
Wang, L ;
Lacey, D ;
Boyle, WJ ;
Hsu, HL .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (07) :3370-3375
[33]  
KURTZ CB, 1990, J IMMUNOL, V144, P3581
[34]   Expression of BAFF (BLyS) in T cells infiltrating labial salivary glands from patients with Sjogren's syndrome [J].
Lavie, F ;
Miceli-Richard, C ;
Quillard, J ;
Roux, S ;
Leclerc, P ;
Mariette, X .
JOURNAL OF PATHOLOGY, 2004, 202 (04) :496-502
[35]   Reduced competitiveness of autoantigen-engaged B cells due to increased dependence on BAFF [J].
Lesley, R ;
Xu, Y ;
Kalled, SL ;
Hess, DM ;
Schwab, SR ;
Shu, HB ;
Cyster, JG .
IMMUNITY, 2004, 20 (04) :441-453
[36]   Mice transgenic for BAFF develop lymphocytic disorders along with autoimmune manifestations [J].
Mackay, F ;
Woodcock, SA ;
Lawton, P ;
Ambrose, C ;
Baetscher, M ;
Schneider, P ;
Tschopp, J ;
Browning, JL .
JOURNAL OF EXPERIMENTAL MEDICINE, 1999, 190 (11) :1697-1710
[37]   BAFF and APRIL: A tutorial on B cell survival [J].
Mackay, F ;
Schneider, P ;
Rennert, P ;
Browning, J .
ANNUAL REVIEW OF IMMUNOLOGY, 2003, 21 :231-264
[38]   Intracerebral expression of CXCL13 and BAFF is accompanied by formation of lymphoid follicle-like structures in the meninges of mice with relapsing experimental autoimmune encephalomyelitis [J].
Magliozzi, R ;
Columba-Cabezas, S ;
Serafini, B ;
Aloisi, F .
JOURNAL OF NEUROIMMUNOLOGY, 2004, 148 (1-2) :11-23
[39]   The level of BLyS (BAFF) correlates with the titre of autoantibodies in human Sjogren's syndrome [J].
Mariette, X ;
Roux, S ;
Zhang, J ;
Bengoufa, D ;
Lavie, F ;
Zhou, T ;
Kimberly, R .
ANNALS OF THE RHEUMATIC DISEASES, 2003, 62 (02) :168-171
[40]   Interaction of the TNF homologues BLyS and APRIL with the TNF receptor homologues BCMA and TACI [J].
Marsters, SA ;
Yan, MH ;
Pitti, RM ;
Haas, PE ;
Dixit, VM ;
Ashkenazi, A .
CURRENT BIOLOGY, 2000, 10 (13) :785-788